{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T22:53:07Z","timestamp":1771368787725,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T00:00:00Z","timestamp":1501891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.prnil.2017.10.001","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T15:46:48Z","timestamp":1507996008000},"page":"61-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["General practitioner perception of prostate-specific antigen testing has improved, but more awareness of prostate cancer risk in younger patients is still awaited"],"prefix":"10.1016","volume":"6","author":[{"given":"David R.","family":"Thurtle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma M.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Brierly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciaran J.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prnil.2017.10.001_bib1","unstructured":"Cancer Research UK [Internet]; Prostate cancer statistics. Available from: http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\/types\/prostate\/. Accessed November 2016."},{"issue":"4","key":"10.1016\/j.prnil.2017.10.001_bib2","first-page":"1427","article-title":"Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994","volume":"158","author":"Newcomer","year":"1997","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.prnil.2017.10.001_bib3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.prnil.2017.10.001_bib4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jama.1993.03510070082041","article-title":"Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges","volume":"270","author":"Oesterling","year":"1993","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.prnil.2017.10.001_bib5","doi-asserted-by":"crossref","unstructured":"Luboldt H-J, Schindler JF, Rubben H. Age-specific reference ranges for prostate-specific antigen as a marker for prostate cancer. EAU-EBU update series 52007. p. 38\u201348.","DOI":"10.1016\/j.eeus.2006.10.003"},{"key":"10.1016\/j.prnil.2017.10.001_bib6","unstructured":"British Association of Urological Surgeons (BAUS) PSA measurements: Frequently asked questions [Internet]. Now available from: http:\/\/www.tsft.nhs.uk\/media\/45224\/PSA_levels.pdf. Originally accessed March 2016."},{"issue":"3","key":"10.1016\/j.prnil.2017.10.001_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119494","article-title":"Trends and outcome from radical therapy for primary nonmetastatic prostate cancer in a UK population","volume":"10","author":"Greenberg","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prnil.2017.10.001_bib8","series-title":"National Institute for Health and Clinical Excellence Clinical Knowledge Summaries: prostate cancer","author":"National Institute for Health and Care Excellence (NICE)","year":"2011"},{"key":"10.1016\/j.prnil.2017.10.001_bib9","series-title":"NICE CG97: Lower urinary tract symptoms in men: management","author":"National Institute for Health and Care Excellence (NICE)","year":"2010"},{"key":"10.1016\/j.prnil.2017.10.001_bib10","unstructured":"National Institute for Health and Care Excellence (NICE); Suspected cancer: recognition and referral (NG12). Available from: https:\/\/www.nice.org.uk\/guidance\/ng12. Accessed March 2017."},{"issue":"5","key":"10.1016\/j.prnil.2017.10.001_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1308\/003588408X301019","article-title":"Perception of abnormal serum prostate-specific antigen (PSA) test results amongst family practitioners","volume":"90","author":"Rochester","year":"2008","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.prnil.2017.10.001_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1502","article-title":"Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes","volume":"348","author":"Sooriakumaran","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.prnil.2017.10.001_bib13","series-title":"Improving outcomes: a strategy for cancer","author":"Department of Health","year":"2011"},{"issue":"9","key":"10.1016\/j.prnil.2017.10.001_bib14","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1464-410X.2011.10163.x","article-title":"Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities","volume":"108","author":"Williams","year":"2011","journal-title":"BJU Int"},{"issue":"641","key":"10.1016\/j.prnil.2017.10.001_bib15","doi-asserted-by":"crossref","first-page":"e845","DOI":"10.3399\/bjgp15X687649","article-title":"Association of GPs' risk attitudes, level of empathy, and burnout status with PSA testing in primary care","volume":"65","author":"Pedersen","year":"2015","journal-title":"Br J Gen Pract"},{"issue":"3","key":"10.1016\/j.prnil.2017.10.001_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006367","article-title":"Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study","volume":"5","author":"Pickles","year":"2015","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.prnil.2017.10.001_bib17","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1464-410X.2006.06481.x","article-title":"Prostate-specific antigen testing: uncovering primary care influences","volume":"98","author":"Gormley","year":"2006","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.prnil.2017.10.001_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/07853890109002068","article-title":"Molecular genetics of prostate cancer","volume":"33","author":"Elo","year":"2001","journal-title":"Ann Med"},{"issue":"18","key":"10.1016\/j.prnil.2017.10.001_bib19","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.prnil.2017.10.001_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/345310","article-title":"Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene","volume":"72","author":"Edwards","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.prnil.2017.10.001_bib21","series-title":"PSA testing in asymptomatic men. Evidence document. Prostate cancer risk management programme information for primary care","author":"Burford","year":"2010"}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888217301058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888217301058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:00:16Z","timestamp":1762419616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2287888217301058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S2287888217301058"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2017.10.001","relation":{},"ISSN":["2287-8882"],"issn-type":[{"value":"2287-8882","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"General practitioner perception of prostate-specific antigen testing has improved, but more awareness of prostate cancer risk in younger patients is still awaited","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2017.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Asian Pacific Prostate Society, Published by Elsevier Korea LLC.","name":"copyright","label":"Copyright"}]}}